The effect of Campylobacter concisus on expression of IL-18, TNF-α and p53 in barrett’s cell lines

Jundishapur Journal of Microbiology

Volumn 8, Issue 12, 2015, Pages

  Namin, Behrooz Mozaffari ^a,b   Dallal, Mohammad Mehdi Soltan ^a,c   Daryani, Nasser Ebrahimi ^d  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Barrett oesophagus; Campylobacter concisus; Genes; Interleukin 18; P53; Tumour necrosis factor alpha (TNF )

Indexed keywords

INTERLEUKIN 18; MESSENGER RNA; TUMOR MARKER; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BARRETT ESOPHAGUS; CAMPYLOBACTER CONCISUS; CARCINOGENESIS; CELL LINE; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; GENE EXPRESSION; NONHUMAN; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

EID: 84950985245     PISSN: 20083645     EISSN: 20084161     Source Type: Journal    
DOI: 10.5812/jjm.26393     Document Type: Article

References (39)

1. Spechler SJ, Fitzgerald RC, Prasad GA, Wang KK. History, molecular mechanisms, and endoscopic treatment of Barrett's esophagus. Gastroenterology. 2010;138(3):854-69. doi: 10.1053/j. gastro.2010.01.002. [PubMed: 20080098]
2. de Jonge PJ, van Blankenstein M, Grady WM, Kuipers EJ. Barrett's oesophagus: epidemiology, cancer risk and implications for management. Gut. 2014;63(1):191-202. doi: 10.1136/ gutjnl-2013-305490. [PubMed: 24092861]
3. Yang L, Lu X, Nossa CW, Francois F, Peek RM, Pei Z. Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome. Gastroenterology. 2009;137(2):588-97. doi: 10.1053/j.gastro.2009.04.046. [PubMed: 19394334]
4. Blackett KL, Siddhi SS, Cleary S, Steed H, Miller MH, Macfarlane S, et al. Oesophageal bacterial biofilm changes in gastro-oesophageal reflux disease, Barrett's and oesophageal carcinoma: association or causality? Aliment Pharmacol Ther. 2013;37(11):1084-92. doi: 10.1111/apt.12317. [PubMed: 23600758]
5. Macfarlane GT, Blackett KL, Nakayama T, Steed H, Macfarlane S. The gut microbiota in inflammatory bowel disease. Curr Pharm Des. 2009;15(13):1528-36. [PubMed: 19442170]
6. Kaakoush NO, Deshpande NP, Wilkins MR, Tan CG, Burgos-Portugal JA, Raftery MJ, et al. The pathogenic potential of Campylobacter concisus strains associated with chronic intestinal diseases. PLoS One. 2011;6(12):e29045. doi: 10.1371/journal. pone.0029045. [PubMed: 22039478]
7. Mukhopadhya I, Thomson JM, Hansen R, Berry SH, El-Omar EM, Hold GL. Detection of Campylobacter concisus and other Campylobacter species in colonic biopsies from adults with ulcerative colitis. PLoS One. 2011;6(6):e21490. doi: 10.1371/journal. pone.0021490. [PubMed: 22039478]
8. Kaakoush NO, Mitchell HM. Campylobacter concisus-A new player in intestinal disease. Front Cell Infect Microbiol. 2012;2:4. doi: 10.3389/fcimb.2012.00004. [PubMed: 22919596]
9. Man SM, Kaakoush NO, Leach ST, Nahidi L, Lu HK, Norman J, et al. Host attachment, invasion, and stimulation of proinflammatory cytokines by Campylobacter concisus and other non-Campylobacter jejuni Campylobacter species. J Infect Dis. 2010;202(12):1855-65. doi: 10.1086/657316. [PubMed: 21050118]
10. Kaakoush NO, Man SM, Lamb S, Raftery MJ, Wilkins MR, Kovach Z, et al. The secretome of Campylobacter concisus. FEBS J. 2010;277(7):1606-17. doi: 10.1111/j.1742-4658.2010.07587.x. [PubMed: 20148967]
11. Mahendran V, Tan YS, Riordan SM, Grimm MC, Day AS, Lemberg DA, et al. The prevalence and polymorphisms of zonula occluden toxin gene in multiple Campylobacter concisus strains isolated from saliva of patients with inflammatory bowel disease and controls. PLoS One. 2013;8(9):e75525. doi: 10.1371/journal. pone.0075525. [PubMed: 24086553]
12. Clemons NJ, Phillips WA, Lord RV. Signaling pathways in the molecular pathogenesis of adenocarcinomas of the esophagus and gastroesophageal junction. Cancer Biol Ther. 2013;14(9):782-95. doi: 10.4161/cbt.25362. [PubMed: 23792587]
13. Man SM, Zhang L, Day AS, Leach ST, Lemberg DA, Mitchell H. Campylobacter concisus and other Campylobacter species in children with newly diagnosed Crohn's disease. Inflamm Bowel Dis. 2010;16(6):1008-16. doi: 10.1002/ibd.21157. [PubMed: 19885905]
14. Ismail Y, Mahendran V, Octavia S, Day AS, Riordan SM, Grimm MC, et al. Investigation of the enteric pathogenic potential of oral Campylobacter concisus strains isolated from patients with inflammatory bowel disease. PLoS One. 2012;7(5):e38217. doi: 10.1371/ journal.pone.0038217. [PubMed: 22666490]
15. Kalischuk LD, Inglis GD. Comparative genotypic and pathogenic examination of Campylobacter concisus isolates from diarrheic and non-diarrheic humans. BMC Microbiol. 2011;11:53. doi: 10.1186/1471-2180-11-53. [PubMed: 21406111]
16. Mozaffari Namin B, Daryani NE, Mirshafiey A, Yazdi MK, Dallal MM. Effect of probiotics on the expression of Barrett's oesophagus biomarkers. J Med Microbiol. 2015;64(Pt 4):348-54. doi: 10.1099/jmm.0.000039. [PubMed: 25666837]
17. Engberg J, Bang DD, Aabenhus R, Aarestrup FM, Fussing V, Gerner-Smidt P. Campylobacter concisus: an evaluation of certain phenotypic and genotypic characteristics. Clin Microbiol Infect. 2005;11(4):288-95. doi: 10.1111/j.1469-0691.2005.01111.x. [PubMed: 15760425]
18. Furrie E, Macfarlane S, Kennedy A, Cummings JH, Walsh SV, O'Neil D A, et al. Synbiotic therapy (Bifidobacterium longum/ Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial. Gut. 2005;54(2):242-9. doi: 10.1136/gut.2004.044834. [PubMed: 15647189]
19. Bourdon JC, Fernandes K, Murray-Zmijewski F, Liu G, Diot A, Xirodimas DP, et al. p53 isoforms can regulate p53 transcriptional activity. Genes Dev. 2005;19(18):2122-37. doi: 10.1101/gad.1339905. [PubMed: 16131611]
20. Younes M. Molecular Pathology of Barrett's Metaplasia and Esophageal Adenocarcinoma. In: Sepulveda AR, Lynch JP, editors. Molecular Pathology of Neoplastic Gastrointestinal Diseases. US: Springer; 2013. pp. 43-52.
21. Abdel-Latif MM, O'Riordan J, Windle HJ, Carton E, Ravi N, Kelleher D, et al. NF-kappaB activation in esophageal adenocarcinoma: relationship to Barrett's metaplasia, survival, and response to neoadjuvant chemoradiotherapy. Ann Surg. 2004;239(4):491-500. [PubMed: 15024310]
22. Ye ZB, Ma T, Li H, Jin XL, Xu HM. Expression and significance of intratumoral interleukin-12 and interleukin-18 in human gastric carcinoma. World J Gastroenterol. 2007;13(11):1747-51. [PubMed: 17461482]
23. Thong-Ngam D, Tangkijvanich P, Lerknimitr R, Mahachai V, Theamboonlers A, Poovorawan Y. Diagnostic role of serum interleukin-18 in gastric cancer patients. World J Gastroenterol. 2006;12(28):4473-7. [PubMed: 16874857]
24. Colleypriest BJ, Ward SG, Tosh D. How does inflammation cause Barrett's metaplasia? Curr Opin Pharmacol. 2009;9(6):721-6. doi: 10.1016/j.coph.2009.09.005. [PubMed: 19828375]
25. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature. 2006;441(7092):431-6. doi: 10.1038/nature04870. [PubMed: 16724054]
26. Rahman MM, McFadden G. Modulation of NF-kappaB signalling by microbial pathogens. Nat Rev Microbiol. 2011;9(4):291-306. doi: 10.1038/nrmicro2539. [PubMed: 21383764]
27. Abdel-Latif MM, Kelleher D, Reynolds JV. Potential role of NF-kappaB in esophageal adenocarcinoma: as an emerging molecular target. J Surg Res. 2009;153(1):172-80. doi: 10.1016/j.jss.2007.12.755. [PubMed: 18533190]
28. Tselepis C, Perry I, Dawson C, Hardy R, Darnton SJ, McConkey C, et al. Tumour necrosis factor-alpha in Barrett's oesophagus: a potential novel mechanism of action. Oncogene. 2002;21(39):6071-81. doi: 10.1038/sj.onc.1205731. [PubMed: 12203119]
29. Gibson MK, Dhaliwal AS, Clemons NJ, Phillips WA, Dvorak K, Tong D, et al. Barrett's esophagus: cancer and molecular biology. Ann N Y Acad Sci. 2013;1300:296-314. doi: 10.1111/nyas.12252. [PubMed: 24117650]
30. Picardo SL, Maher SG, O'Sullivan JN, Reynolds JV. Barrett's to oesophageal cancer sequence: a model of inflammatory-driven upper gastrointestinal cancer. Dig Surg. 2012;29(3):251-60. doi: 10.1159/000341498. [PubMed: 22868386]
31. Kaparakis M, Turnbull L, Carneiro L, Firth S, Coleman HA, Parkington HC, et al. Bacterial membrane vesicles deliver peptidoglycan to NOD1 in epithelial cells. Cell Microbiol. 2010;12(3):372-85. doi: 10.1111/j.1462-5822.2009.01404.x. [PubMed: 19888989]
32. Viala J, Chaput C, Boneca IG, Cardona A, Girardin SE, Moran AP, et al. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol. 2004;5(11):1166-74. doi: 10.1038/ni1131. [PubMed: 15489856]
33. Opitz B, Forster S, Hocke AC, Maass M, Schmeck B, Hippenstiel S, et al. Nod1-mediated endothelial cell activation by Chlamydophila pneumoniae. Circ Res. 2005;96(3):319-26. doi: 10.1161/01. RES.0000155721.83594.2c. [PubMed: 15653568]
34. Istivan TS, Smith SC, Fry BN, Coloe PJ. Characterization of Campylobacter concisus hemolysins. FEMS Immunol Med Microbiol. 2008;54(2):224-35. doi: 10.1111/j.1574-695X.2008.00467.x. [PubMed: 18754784]
35. Gajjar M, Candeias MM, Malbert-Colas L, Mazars A, Fujita J, Olivares-Illana V, et al. The p53 mRNA-Mdm2 interaction controls Mdm2 nuclear trafficking and is required for p53 activation following DNA damage. Cancer Cell. 2012;21(1):25-35. doi: 10.1016/j. ccr.2011.11.016. [PubMed: 22264786]
36. Fichter CD, Herz C, Munch C, Opitz OG, Werner M, Lassmann S. Occurrence of multipolar mitoses and association with Aurora-A/-B kinases and p53 mutations in aneuploid esophageal carcinoma cells. BMC Cell Biol. 2011;12:13. doi: 10.1186/1471-2121-12-13. [PubMed: 21470402]
37. Hritz I, Gyorffy H, Molnar B, Lakatos G, Sipos F, Pregun I, et al. Increased p53 expression in the malignant transformation of Barrett's esophagus is accompanied by an upward shift of the proliferative compartment. Pathol Oncol Res. 2009;15(2):183-92. doi: 10.1007/s12253-008-9095-z. [PubMed: 18752044]
38. Zarrilli R, Ricci V, Romano M. Molecular response of gastric epithelial cells to Helicobacter pylori-induced cell damage. Cell Microbiol. 1999;1(2):93-9. [PubMed: 11207544]
39. Hofman VJ, Moreilhon C, Brest PD, Lassalle S, Le Brigand K, Sicard D, et al. Gene expression profiling in human gastric mucosa infected with Helicobacter pylori. Mod Pathol. 2007;20(9):974-89. doi: 10.1038/modpathol.3800930. [PubMed: 17643099]